artenimol and Anemia
artenimol has been researched along with Anemia in 15 studies
Research
Studies (15)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Banda, S; Blomberg, B; Idro, R; Kühl, MJ; Mukaka, M; Nkosi-Gondwe, T; O Ter Kuile, F; Opoka, RO; Phiri, KS; Robberstad, B | 1 |
| Chandler, CIR; Dorsey, G; Drakeley, C; Gonahasa, S; Kamya, MR; Kigozi, SP; Maiteki-Sebuguzi, C; Okiring, J; Rehman, AM; Staedke, SG | 1 |
| Boele van Hensbroek, M; Desai, MR; Dhabangi, A; Idro, R; John, CC; Kariuki, S; Kuya, NA; Kwambai, TK; Onyango, ED; Opoka, R; Otieno, K; Phiri, KS; Robberstad, B; Samuels, AM; Ter Kuile, FO; Wang, D; Watson, V | 1 |
| Adewoye, EO; Agomo, C; Akano, K; Ambe, J; Ayede, AI; Ebenebe, J; Emechebe, G; Ezeigwe, N; Fatunmbi, B; Finomo, F; Folarin, OA; Gbotosho, GO; Happi, CT; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Oyibo, WA; Sowunmi, A; Useh, F; Wammanda, R; Wewe, OA | 1 |
| Aol, G; Bigogo, GM; Desai, M; Hill, J; Laserson, KF; Phillips-Howard, PA; Taegtmeyer, M; Ter Kuile, F; Young, N | 1 |
| Blomberg, B; Gondwe, T; Lange, S; Mukaka, M; Phiri, K; Robberstad, B | 1 |
| Desai, M; Dhabangi, A; Idro, R; John, CC; Kariuki, S; Kwambai, TK; Opoka, R; Phiri, K; Robberstad, B; Samuels, AM; Ter Kuile, FO; van Hensbroek, MB; Wang, D | 1 |
| Blomberg, B; Lange, S; Nkosi-Gondwe, T; Phiri, KS; Robberstad, B | 1 |
| Charlebois, E; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muhindo, MK; Nalugo, N; Okiring, J; Olwoch, P; Opira, B; Ruel, T | 1 |
| Amuge, P; Brooker, SJ; Dorsey, G; Kamya, MR; Kiwanuka, N; Nankabirwa, JI; Rosenthal, PJ; Staedke, SG; Wandera, B | 1 |
| Bass, JK; Bigira, V; Boivin, MJ; Dorsey, G; Familiar-Lopez, I; Kamya, M; Kapisi, J; Muhindo, M; Nakasujja, N; Opoka, RO; Ruiseñor-Escudero, H; Sikorskii, A | 1 |
| Aderoyeje, T; Adewoye, EO; Akano, K; Ayede, AI; Fatunmbi, B; Ntadom, G; Sowunmi, A | 1 |
| Bélard, S; Damm, G; Kim, J; Kurth, F; Lingscheid, T; Mayer, B; Menner, N; Pongratz, P; Salama, A; Seehofer, D; Stegemann, MS; Steiner, F; Suttorp, N; von Bernuth, H; Zoller, T | 1 |
| Ashley, EA; Brockman, A; Chan, S; Goubert, L; Janssens, B; Nong, S; Socheat, D; Uong, S; Van Damme, W; van Herp, M | 1 |
| Anstey, NM; Ebsworth, EP; Kenangalem, E; Laihad, F; Maristela, R; Price, RN; Ratcliff, A; Siswantoro, H; Tjitra, E; Wuwung, RM | 1 |
Trials
12 trial(s) available for artenimol and Anemia
| Article | Year |
|---|---|
Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial.
Topics: Aftercare; Anemia; Antimalarials; Artemisinins; Child, Preschool; Delivery of Health Care; Drug Combinations; Female; Health Facilities; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Patient Discharge; Plasmodium falciparum; Quinolines; Social Welfare | 2021 |
Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).
Topics: Adolescent; Anemia; Antimalarials; Artemisinins; Child; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Humans; Malaria; Male; Prevalence; Quinolines; Students; Uganda | 2019 |
Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
Topics: Aftercare; Anemia; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Humans; Infant; Kenya; Malaria; Male; Patient Readmission; Quinolines; Uganda | 2020 |
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial.
Topics: Anemia; Antimalarials; Artemisinins; Child, Preschool; Drug Administration Schedule; Humans; Infant; Malaria; Malawi; Medication Adherence; Quinolines | 2018 |
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, sup
Topics: Anemia; Artemisinins; Chemoprevention; Child, Preschool; Double-Blind Method; Drug Combinations; Humans; Infant; Infant, Newborn; Kenya; Malaria; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Sample Size; Uganda | 2018 |
Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivation.
Topics: Anemia; Antimalarials; Artemisinins; Attitude of Health Personnel; Caregivers; Chemoprevention; Child; Child, Preschool; Community Health Workers; Drug Combinations; Feasibility Studies; Female; Focus Groups; Government Programs; House Calls; Humans; Infant; Inservice Training; Malaria; Malawi; Male; Motivation; Patient Discharge; Perception; Qualitative Research; Quinolines; Workload | 2018 |
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Incidence; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Risk Assessment; Uganda; Withholding Treatment | 2019 |
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
Topics: Anemia; Antimalarials; Artemisinins; Child; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Parasitemia; Prevalence; Quinolines; Risk Factors; Uganda | 2014 |
Malaria illness mediated by anaemia lessens cognitive development in younger Ugandan children.
Topics: Age Factors; Anemia; Antimalarials; Artemisinins; Child, Preschool; Cognition; Cognition Disorders; Coinfection; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2016 |
Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malaria.
Topics: Adolescent; Amodiaquine; Anemia; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Prognosis; Quinolines; Risk Factors; Time Factors; Treatment Outcome | 2016 |
A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
Topics: Adolescent; Adult; Aged; Anemia; Antimalarials; Artemisinins; Artesunate; Cambodia; Child; Child, Preschool; Drug Therapy, Combination; Female; Genome, Protozoan; Humans; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome | 2007 |
Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Topics: Adolescent; Adult; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Diarrhea; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Ethanolamines; Female; Fluorenes; Humans; Indonesia; Infant; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Prospective Studies; Quinolines; Recurrence; Sesquiterpenes; Treatment Outcome; Urticaria; Vomiting | 2007 |
Other Studies
3 other study(ies) available for artenimol and Anemia
| Article | Year |
|---|---|
Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials.
Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemisinins; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Hematocrit; Humans; Infant; Kaplan-Meier Estimate; Logistic Models; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Odds Ratio; Quinolines; ROC Curve; Treatment Outcome | 2017 |
Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.
Topics: Adult; Anemia; Anti-Bacterial Agents; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Dietary Supplements; Erythromycin; Female; Folic Acid; Guideline Adherence; Health Personnel; HIV Infections; Humans; Iron, Dietary; Kenya; Laboratory Proficiency Testing; Longitudinal Studies; Malaria; Penicillins; Point-of-Care Testing; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prenatal Care; Quinine; Quinolines; Syphilis; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Antimalarials; Artemether; Artemisinins; Child; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hemolysis; Humans; Lumefantrine; Malaria, Falciparum; Male; Prospective Studies; Quinolines | 2016 |